Dietary vitamin K and therapeutic warfarin alter the susceptibility to vascular calcification in experimental chronic kidney disease

Kidney International

Volumn 83, Issue 5, 2013, Pages 835-844

  McCabe, Kristin M ^a   Booth, Sarah L ^b   Fu, Xueyan ^b   Shobeiri, Navid ^a   Pang, Judith J ^a   Adams, Michael A ^a   Holden, Rachel M ^a  

^a QUEEN S UNIVERSITY   (Canada)

^b TUFTS UNIVERSITY   (United States)

Author keywords

chronic kidney disease; hyperphosphatemia; pulse wave velocity; renal pathology; vascular calcification; vascular disease

Indexed keywords

CALCIUM; MENATETRENONE; OSTEOCALCIN; PHYTOMENADIONE; VITAMIN K GROUP; WARFARIN;

ABDOMINAL AORTA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL CALCIFICATION; CAROTID ARTERY; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DISEASE SEVERITY; MALE; NONHUMAN; PRIORITY JOURNAL; PULSE PRESSURE; PULSE WAVE; RAT; RENAL ARTERY; THORACIC AORTA; VITAMIN INTAKE;

EID: 84877054086     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2012.477     Document Type: Article

References (35)

1. Andrade J, Ignaszewski AA. Cardiovascular risk assessment: identification of individuals at increased risk. BCMJ 2008; 50: 246-251.
2. Sigrist MK, Taal MW, Bungay P et al. Progressive vascular calcification over 2 years is associated with arterial stiffening and increased mortality in patients with stages 4 and 5 chronic kidney disease. Clin J Am Soc Nephrol 2007; 2: 1241-1248.
3. Price PA, Faus SA, Williamson MK. Warfarin causes rapid calcification of the elastic lamellae in rat arteries and heart valves. Arterioscler Thromb Vasc Biol 1998; 18: 1400-1407.
4. Garland JS, Holden RM, Groome PA et al. Prevalence and associations of coronary artery calcification in patients with stages 3 to 5 CKD without cardiovascular disease. Am J Kidney Dis 2008; 52: 849-858.
5. Holden RM, Iliescu E, Morton AR et al. Vitamin K status of Canadian peritoneal dialysis patients. Perit Dial Int 2008; 28: 415-418.
6. Holden RM, Morton AR, Garland JS et al. Vitamins K and D status in stages 3-5 chronic kidney disease. Clin J Am Society Nephrol 2010; 5: 590-597.
7. Westenfeld R, Krueger T, Schlieper G et al. Effect of vitamin K2 supplementation on functional vitamin K deficiency in hemodialysis patients: a randomized trial. Am J Kidney Dis 2012; 59: 186-195.
8. Miller LM, Hopman WM, Garland JS et al. Cardioprotective medication use in hemodialysis patients. Can J Cardiol 2006; 22: 755-760.
9. Holden RM, Sanfilippo AS, Hopman WM et al. Warfarin and aortic valve calcification in hemodialysis patients. J Nephrol 2007; 20: 417-422.
10. Thijssen HH, Drittij-Reijnders MJ, Fischer MA. Phylloquinone and menaquinone-4 distribution in rats: synthesis rather than uptake determines menaquinone-4 organ concentrations. J Nutr 1996; 126: 537-543.
11. Thijssen HH, Vervoort LM, Schurgers LJ et al. Menadione is a metabolite of oral vitamin K. Br J Nutr 2006; 95: 260-266.
12. Okano T, Shimomura Y, Yamane M et al. Conversion of phylloquinone (vitamin K1) into menaquinone-4 (vitamin K2) in mice: two possible routes for menaquinone-4 accumulation in cerebra of mice. J Biol Chem 2008; 283: 11270-11279.
13. Rajabi AA, Booth SL, Peterson JW et al. Deuterium-labeled phylloquinone has tissue-specific conversion to Menaquinone-4 among Fischer 344 male rats. J Nutr 2012; 142: 841-845.
14. Schurgers LJ, Spronk HM, Soute BA et al. Regression of warfarin-induced medial elastocalcinosis by high intake of vitamin K in rats. Blood 2007; 109: 2823-2831.
15. Spronk HM, Soute BA, Schurgers LJ et al. Tissue-specific utilization of menaquinone-4 results in the prevention of arterial calcification in warfarin-treated rats. J Vasc Res 2003; 40: 531-537.
16. Shobeiri N, Adams MA, Holden RM. Vascular calcification in animal models of CKD: A review. Am J Nephrol 2010; 31: 471-481.
17. Wizemann V, Tong L, Satayathum S et al. Atrial fibrillation in hemodialysis patients: clinical features and associations with anticoagulant therapy. Kidney Int 2010; 77: 1098-1106.
18. Shea MK, O'Donnell CJ, Hoffmann U et al. Vitamin K supplementation and progression of coronary artery calcium in older men and women. Am J Clin Nutr 2009; 89: 1799-1807.
19. Shiraki M, Shiraki Y, Aoki C et al. Vitamin K2 (menatetrenone) effectively prevents fractures and sustains lumbar bone mineral density in osteoporosis. J Bone Min Res 2000; 15: 515-521.
20. Ogirima T, Tano K, Kanehara M et al. Sex difference of adenine effects in rats: renal function, bone mineral density and sex steroidogenesis. Endocr J 2006; 53: 407-413.
21. De Schutter TM, Neven E, Persy VP et al. Vascular calcification is associated with cortical bone loss in chronic renal failure rats with and without ovariectomy: the calcification paradox. Am J Nephrol 2011; 34: 356-366.
22. Taggart WV, Matschiner JT. Metabolism of menadione-6,7-3H in the rat. Biochemistry 1969; 8: 1141-1146.
23. Davidson RT, Foley AL, Engelke JA et al. Conversion of dietary phylloquinone to tissue menaquinone-4 in rats is not dependent on gut bacteria. J Nutr 1998; 128: 220-223.
24. Price PA, Roublick AM, Williamson MK. Artery calcification in uremic rats is increased by a low protein diet and prevented by treatment with ibandronate. Kidney Int 2006; 70: 1577-1583.
25. Du F, Higginbotham DA, White BD. Food intake, energy balance and serum leptin concentrations in rats fed low-protein diets. J Nutr 2000; 130: 514-521.
26. Henley C, Davis J, Miller G et al. The calcimimetic AMG 641 abrogates parathyroid hyperplasia, bone and vascular calcification abnormalities in uremic rats. Eur J Pharmacol 2009; 616: 306-313.
27. Matsui I, Hamano T, Mikami S et al. Fully phosphorylated fetuin-A forms a mineral complex in the serum of rats with adenine-induced renal failure. Kidney Int 2009; 75: 915-928.
28. Booth SL, Peterson JW, Smith D et al. Age and dietary form of vitamin K affect menaquinone-4 concentrations in male Fischer 344 rats. J Nutr 2008; 138: 492-496.
29. Carrie I, Portoukalian J, Vicaretti R et al. Menaquinone-4 concentration is correlated with sphingolipid concentrations in rat brain. J Nutr 2004; 134: 167-172.
30. Heresztyn T, Nicholson BC. A colorimetric protein phosphatase inhibition assay for the determination of cyanobacterial peptide hepatotoxins based on the dephosphorylation of phosvitin by recombinant protein phosphatase 1. Environ Toxicol 2001; 16: 242-252.
31. Booth SL, Dallal G, Shea MK et al. Effect of vitamin K supplementation on bone loss in elderly men and women. J Clin Endocrinol Metab 2008; 93: 1217-1223.
32. Sadowski JA, Hood SJ, Dallal GE et al. Phylloquinone in plasma from elderly and young adults: factors influencing its concentration. Am J Clin Nutr 1989; 50: 100-108.
33. Proudfoot D, Skepper JN, Shanahan CM et al. Calcification of human vascular cells in vitro is correlated with high levels of matrix Gla protein and low levels of osteopontin expression. Arterioscler Thromb Vasc Biol 1998; 18: 379-388.
34. Proudfoot D, Skepper JN, Hegyi L et al. Apoptosis regulates human vascular calcification in vitro: evidence for initiation of vascular calcification by apoptotic bodies. Circ Res 2000; 87: 1055-1062.
35. Essalihi R, Dao HH, Yamaguchi N et al. A new model of isolated systolic hypertension induced by chronic warfarin and vitamin K1 treatment. Am J Hypertens 2003; 16: 103-110.